Living Cell Technologies Limited
LVCLY · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 1,134% | -98.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 98.7% | 78.2% | 81.6% |
| R&D Expenses | $1 | $1 | $1 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | -5,068.3% | -69,781.2% | -849.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$2 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | -5,016.3% | -57,483.1% | -544.6% |
| EPS | -0.013 | -0.016 | -0.022 | -0.024 |
| % Growth | 18.8% | 27.3% | 8.3% | – |
| EPS Diluted | -0.013 | -0.016 | -0.022 | -0.024 |
| Weighted Avg Shares Out | 166 | 135 | 89 | 61 |
| Weighted Avg Shares Out Dil | 166 | 135 | 89 | 61 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | – | -3,015.6% | -42,848.3% | -498.3% |